Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to collect data about how well U-100 Regular Human Insulin can be used in the V-Go Insulin Delivery Device compared to U-100 Rapid Acting Insulin in the V-Go Insulin Delivery Device. The data collected will be used to see how much subjects' blood sugar levels change over time after they switch from using U-100 Rapid Acting Insulin to U-100 Regular Human Insulin within their V-Go Insulin Delivery Device.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03495908
Study type Interventional
Source East Coast Institute for Research
Contact
Status Recruiting
Phase N/A
Start date April 9, 2018
Completion date December 31, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT03436212 - Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump. N/A
Completed NCT03244800 - A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus. Phase 2
Not yet recruiting NCT03625856 - The Effect of Chlorella Supplementation on Patients With Type 2 Diabetes Mellitus N/A
Withdrawn NCT02769091 - A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes Phase 2
Completed NCT03296800 - Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects Phase 1
Active, not recruiting NCT03248401 - Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes Phase 4
Completed NCT03644134 - A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns N/A
Completed NCT02836873 - Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment Phase 3
Completed NCT02226003 - Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017) Phase 3
Completed NCT02252224 - Forxiga (Dapagliflozin) Regulatory Postmarketing Surveillance N/A
Completed NCT00736879 - Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Phase 3
Completed NCT02471404 - Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea Phase 4
Recruiting NCT03279263 - An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy Phase 2
Terminated NCT02549924 - Effect of Administration of Resveratrol on Glycemic Variability in Individuals With Type 2 Diabetes Mellitus Phase 2
Completed NCT02851849 - A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus Phase 2
Completed NCT02916706 - Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus Phase 3
Completed NCT02924064 - Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes Mellitus Phase 3
Recruiting NCT02745808 - Injectable Collagen Scaffold™ Combined With HUC-MSCs for the Improvement of Erectile Function in Men With Diabetes Phase 1
Not yet recruiting NCT02548741 - Evaluation of the Metformin Effect on Methylglyoxal in Patients With Type 2 Diabetes N/A
Completed NCT02526524 - Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Phase 2